Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gibb

Showing results (191-200 of 208) with videos related to

Pageof 21
Sort By:
British Journal of Haematology|April 10, 2024
Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UKA Kuhnl, C Roddie, A A Kirkwood, et al.
Cancer|March 27, 2019
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trialJames M Cleary, Nora K Horick, Nadine Jackson McCleary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerRoland Seiler, Ewan A Gibb, Natalie Q Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Molecular Characterization of Neuroendocrine-like Bladder CancerJosé Batista da Costa, Ewan A Gibb, Trinity J Bivalacqua, et al.
Nature Communications|September 27, 2019
High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC programDavid P Labbé, Giorgia Zadra, Meng Yang, et al.
Nature Communications|December 22, 2021
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancerNeha Singh, Varune R Ramnarine, Jin H Song, et al.
European Urology|April 10, 2017
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant ChemotherapyRoland Seiler, Hussam Al Deen Ashab, Nicholas Erho, et al.
Cancer Cell|January 10, 2018
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal MelanomaA Gordon Robertson, Juliann Shih, Christina Yau, et al.
European Urology|February 11, 2020
Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al.
Cancer Cell|August 16, 2017
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal MelanomaA Gordon Robertson, Juliann Shih, Christina Yau, et al.
Pageof 21

Showing results (191-200 of 208) with videos related to

Sort By:
Pageof 21
British Journal of Haematology|April 10, 2024
Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UKA Kuhnl, C Roddie, A A Kirkwood, et al.
Cancer|March 27, 2019
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trialJames M Cleary, Nora K Horick, Nadine Jackson McCleary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerRoland Seiler, Ewan A Gibb, Natalie Q Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Molecular Characterization of Neuroendocrine-like Bladder CancerJosé Batista da Costa, Ewan A Gibb, Trinity J Bivalacqua, et al.
Nature Communications|September 27, 2019
High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC programDavid P Labbé, Giorgia Zadra, Meng Yang, et al.
Nature Communications|December 22, 2021
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancerNeha Singh, Varune R Ramnarine, Jin H Song, et al.
European Urology|April 10, 2017
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant ChemotherapyRoland Seiler, Hussam Al Deen Ashab, Nicholas Erho, et al.
Cancer Cell|January 10, 2018
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal MelanomaA Gordon Robertson, Juliann Shih, Christina Yau, et al.
European Urology|February 11, 2020
Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al.
Cancer Cell|August 16, 2017
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal MelanomaA Gordon Robertson, Juliann Shih, Christina Yau, et al.
Pageof 21